| Today's News and Trends | Kevin Kadakia, MD, MBA, and Tarang Patel, DO, officially announced the rollout of Radiology One March 1 with a team of 25-plus rads. Kevin Kadakia, MD, MBA, and Tarang Patel, DO, officially announced the rollout of Radiology One March 1 with a team of 25-plus rads. | | |
| House Republicans on Saturday released a seven-month funding patch to avert a government shutdown, adding billions for deportations, veterans' healthcare and the military. House Republicans on Saturday released a seven-month funding patch to avert a government shutdown, adding billions for deportations, veterans' healthcare and the military. | | |
| The Conrad State 30 and Physician Access Reauthorization Act is endorsed by the ACR, AMA and the American Hospital Association. The Conrad State 30 and Physician Access Reauthorization Act is endorsed by the ACR, AMA and the American Hospital Association. | | |
| The Los Angeles-based imaging center operator recently inked a partnership with a Florida OB-GYN group and plans to "aggressively" pursue similar opportunities. The Los Angeles-based imaging center operator recently inked a partnership with a Florida OB-GYN group and plans to "aggressively" pursue similar opportunities. | | |
| | This marks the first major update to the HIPAA Security Rule in over a decade, with HHS seeking to require multifactor authentication and written documentation of all policies. This marks the first major update to the HIPAA Security Rule in over a decade, with HHS seeking to require multifactor authentication and written documentation of all policies. | | |
| About 282 (or 1%) of radiologists worked for PE entities in 2013, a number that has increased over 1,300% in the 11 years since, according to new research. About 282 (or 1%) of radiologists worked for PE entities in 2013, a number that has increased over 1,300% in the 11 years since, according to new research. | | |
| The publicly traded Broomfield, Colorado, firm plans to bolster access to its Nociscan product across key markets in New York and New Jersey. The publicly traded Broomfield, Colorado, firm plans to bolster access to its Nociscan product across key markets in New York and New Jersey. | | |
| |
|
| ![]() | |
|
